DRD2 and non-small cell lung carcinoma: For example, one in silico screen using shRNA library‐identified gene signatures to find drugs that could synergize with EGFR inhibitor gefitinib in NSCLC identified thioridazine, an antipsychotic DRD2 antagonist, and showed that the two drugs synergistically induced cell death in vitro [15].